Vanda Pharmaceuticals (VNDA) Depreciation and Depletion (2011 - 2026)

Vanda Pharmaceuticals (VNDA) has 14 years of Depreciation and Depletion data on file, last reported at $273000.0 in Q1 2026.

• For the quarter ending Q1 2026, Depreciation and Depletion rose 18.18% year-over-year to $273000.0; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 29.19% YoY), and the FY2025 full-year result was $1.1 million, up 28.06% from the prior year.
• Depreciation and Depletion retreated to $273000.0 in Q1 2026, from $301000.0 in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $323000.0 in Q1 2022 to a low of $200000.0 in Q3 2023.
• A 5-year average of $257000.0 and a median of $267000.0 in 2025 frame the typical range for Depreciation and Depletion.
• Across the five-year window, Depreciation and Depletion plunged 33.11% in 2023 and soared 39.35% in 2025, its largest moves.
• Tracing VNDA's Depreciation and Depletion over 5 years: stood at $284000.0 in 2022, then dropped by 27.82% to $205000.0 in 2023, then gained by 7.8% to $221000.0 in 2024, then surged by 36.2% to $301000.0 in 2025, then dropped by 9.3% to $273000.0 in 2026.
• Business Quant data shows VNDA's Depreciation and Depletion at $273000.0 in Q1 2026, $301000.0 in Q4 2025, and $301000.0 in Q3 2025.